Bernie Sanders and Elon Musk Unite on Lowering Ozempic Prices

Senator Sanders and Elon Musk both advocate for affordable access to GLP-1 weight loss drugs amid Senate hearings on Novo Nordisk pricing.

Senator Bernie Sanders and Elon Musk agree on the need to make GLP-1 weight loss drugs like Ozempic and Wegovy more affordable.
Sanders criticized Novo Nordisk's CEO during a Senate hearing for charging Americans significantly higher prices compared to other countries.
Novo Nordisk has made $50 billion from Ozempic and Wegovy since 2018, with 72% of revenue coming from U.S. sales.
Sanders secured commitments from major pharmacy benefit managers not to limit coverage if Novo Nordisk lowers drug prices.
Compounding pharmacies in the U.S. are offering cheaper alternatives due to high demand and supply shortages of the drugs.